Log in
Enquire now
Pan Cancer T

Pan Cancer T

Developer of T cell therapies to treat solid tumors

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
CEO
‌
Rachel Abbott
Company Operating Status
Active
Country
Netherlands
Netherlands
Email Address
katrien.reynders@pancancer-t.com
info@pancancer-t.com
Facebook URL
@contact
Founded Date
2020
Founder
‌
Dora Hammerl
‌
Katrien Reynders
‌
Reno Debets
Headquarters
Rotterdam
Rotterdam
Industry
Therapeutics
Therapeutics
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Healthcare
Healthcare
Regenerative medicine
Regenerative medicine
Cell therapy
Cell therapy
Stem cell
Stem cell
Immunotherapy
Immunotherapy
Health technology
Health technology
Investors
Erasmus MC
Erasmus MC
Thuja Capital
Thuja Capital
InnovationQuarter
InnovationQuarter
Van Herk Ventures
Van Herk Ventures
Latest Funding Round Date
December 8, 2025
Latest Funding Round Amount (USD)
11,700,000
Latest Funding Type
Seed
Seed
LinkedIn URL
@contact
Location
Belgium
Belgium
Rotterdam
Rotterdam
Number of Employees (Ranges)
1 – 10
Total Funding Amount (USD)
17,200,000
Twitter URL
@contact
Official Website
pancancer-t.com

Find more companies like Pan Cancer T

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.